Live
Read now
Employees2
LocationPittsburgh, PA

About

At Rezq Bio, we work to offer hope to those on the lonely journey of chronic autoimmune disease. Rezq Bio is an early stage biotech company that seeks to cure Type 1 Diabetes (T1D) and other localized autoimmune conditions. Our lead asset is a Phase 1B/2A ready autologous dendritic cell therapy that treats T1D. T1D is a chronic autoimmune condition caused by the gradual destruction of insulin producing cells within the pancreas resulting in uncontrolled blood sugar. • No approved therapies exist that reverse onset or delay progression • Daily, lifelong insulin supplementation does not prevent complications such as heart disease, nephropathy, blindness, foot amputations, etc. There are approximately 1.6m individuals with Type I Diabetes in the United States and 18m worldwide. • 64k newly diagnosed (“Early Onset”) each year and growing. • $16bn in associated medical costs and lost income annually As a platform, we believe our antisense (ASO) technology can be applied to other localized autoimmune conditions such as Colitis (IND ready), Multiple Sclerosis and Autoimmune Polyneuropathy. Looking forward, we have also delivered microspheres loaded with ASOs as well as RA+TGF-B with success preclinically. This provides an inert, off-the-shelf delivery mechanism that does not require reprogramming one's dendritic cells externally.

Founders

  • Arjun Hattiangadi
  • Dr. David Finegold

Investors

StartUp Health

News

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: rezq.bio

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire